US-based global biopharmaceutical company Pfizer held $203.93bn in market capitalisation and $172.1bn worth assets as of May 2014. The company, which produces diverse healthcare products including human and animal biologic and small molecule medicines and vaccines, as well as nutritional products, recorded sales of $52.67bn and profit of $22bn in 2013.
Pfizer was founded by Charles Pfizer and Charles Erhart in 1849 and is headquartered in New York. The company operates through five segments;, Primary Care, Specialty Care and Oncology, Established Products & Emerging Markets, Animal Health, and Consumer Healthcare, and currently employs 77,700 people.
Swiss multinational pharmaceutical company Novartis had a market value of $227.44bn and $126.3bn worth assets as of May 2014. With its diversified global health care portfolio of patent protected prescription medicines, generic pharmaceuticals, preventive vaccines, diagnostic tools, and animal and consumer healthcare products, the company recorded sales of $57.9bn and a profit of $9.2bn in 2013.
Novartis, headquartered in Basel, Switzerland, was founded in February 1996. The company operates through five segments – Pharmaceuticals (innovative patent protected prescription drugs, Alcon (surgical, ophthalmic pharmaceuticals and vision care products), Sandoz (generic pharmaceuticals), Vaccines and Diagnostics, and Consumer Health, and currently has 135,696 employees.
French multinational pharmaceutical company Sanofi was estimated to hold $137.14bn of market cap and $132.4bn of assets as of May 2014. The company, which is engaged in the research, production and distribution of pharmaceutical products, recorded net sales of $43.75bn and recorded a profit of $4.9bn in 2013.
Headquartered in Paris, Sanofi was founded in 1994. The company operates through three major segments namely, Pharmaceuticals, Human Vaccines and Animal Health, and has 112,128 employees.
Roche Holding, Switzerland
Roche Holding, a Switzerland-based holding company that manufactures, develops and markets diagnostic and therapeutic products, held $253.74bn of market capitalisation and assets worth $69.9bn as of May 2014. The company’s net sales and profit in 2013 stood at $50.46bn and $12bn respectively.
Roche Holding was founded by Fritz Hoffmann-La Roche in October 1896 and is headquartered in Basel. Operating through two broad segments – Roche Diagnostics and Roche Pharmaceuticals – the company currently employs 85,080 people across more than 150 countries.
Merck & Co., USA
Global pharmaceutical company Merck & Co. had $165.8bn market value and $105.6bn of assets as of May 2014. The company’s sales and profit in 2013 stood at $44.09bn and $4.4bn respectively.
Headquartered in Whitehouse Station, New Jersey, Merck was founded in 1851 and is engaged in the discovery, development and marketing of a broad range of human and animal health products including medicines and vaccines. The company operates through four segments: Pharmaceutical, Animal Health, Consumer Care and Alliances, employing 76,000 people.
UK-based global healthcare company GlaxoSmithKline held a $128.8bn market cap and $69.7bn of assets as of May 2014. The company, operating in three primary areas of business – Pharmaceuticals, Vaccines and Consumer Healthcare – recorded sales of $41.43bn and profit of $8.5bn in 2013.
GlaxoSmithKline, founded in December 1999 and headquartered in Brentford, has 99,451 employees across 115 countries. Pharmaceuticals, vaccines, and the company’s consumer healthcare businesses accounted for 67%, 13% and 20% turnover respectively in 2013.
UK-based global biopharmaceutical company AstraZeneca had $82.32bn market value and $55.9bn of assets as of May 2014. The company’s sales and net profit in 2013 were $25.69bn and $2.6bn respectively.
Headquartered in London and founded in April 1999, AstraZeneca is engaged in discovery, development and commercialisation of prescription medicines mainly for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious diseases. The company operates in more than 100 countries and has 51,500 employees.
Eli Lilly & Co., USA
US-based pharmaceutical company Eli Lilly & Co. held $65.86bn market capitalisation and $35.2bn of assets as of May 2014, while its sales and net profit in 2013 were $23.11bn and $4.7bn respectively.
Founded in May 1876 and headquartered in Indianapolis, Eli Lilly & Co. develops, manufactures and sells pharmaceutical products for humans and animals. It employs 37,925 people and markets its products in 125 countries.
Abbott Laboratories, USA
US-based global healthcare and research company Abbott Laboratories had $59.4bn market capitalisation and $43bn of assets as of May 2014. The company, which is engaged in the discovery, development, manufacture and sale of diversified health care products, recorded sales of $21.85bn and profit of $2.6bn in 2013.
Founded in 1888 and headquartered in Abbott Park, Illinois, the company operates through five business segments; Proprietary Pharmaceutical Products, Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. Abbot Laboratories has 69,000 employees at present.
McKesson, a health services and information technology company based in the US, held $40.51bn market capitalisation and $36.5bn of assets as of May 2014. Its net sales and profit in 2013 stood at $130.09bn and $1.2bn respectively.
Founded in 1833 and headquartered in San Francisco, California, McKesson operates through two segments namely, McKesson Distribution Solutions (delivery of pharmaceuticals to retail pharmacies and hospitals) and McKesson Technology Solutions (provider of software, automation, business services and consulting to hospitals, physician offices, and health care agencies). The company employs 43,500 people.